TCT
NVO

TIAA CREF Trust’s Novo Nordisk NVO Stock Holding History

TIAA CREF Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$478K Sell
27,906
-3,666
-12% -$63.8K ﹤0.01% 335
2016
Q4 		$566K Sell
31,572
-8,128
-20% -$147K ﹤0.01% 314
2016
Q3 		$826K Buy
39,700
+1,774
+5% +$44K 0.01% 283
2016
Q2 		$1.02M Buy
37,926
+3,008
+9% +$82.5K 0.01% 262
2016
Q1 		$946K Sell
34,918
-3,464
-9% -$92.8K 0.01% 258
2015
Q4 		$1.11M Buy
38,382
+1,732
+5% +$47.9K 0.01% 233
2015
Q3 		$994K Buy
36,650
+3,372
+10% +$95.5K 0.01% 242
2015
Q2 		$911K Sell
33,278
-65,690
-66% -$1.85M 0.01% 243
2015
Q1 		$2.64M Sell
98,968
-752
-0.8% -$17.3K 0.03% 165
2014
Q4 		$2.11M Buy
99,720
+474
+0.5% +$10.6K 0.03% 176
2014
Q3 		$2.36M Sell
99,246
-1,252
-1% -$28.8K 0.03% 169
2014
Q2 		$2.32M Sell
100,498
-666
-0.7% -$14.7K 0.03% 165
2014
Q1 		$2.31M Buy
+101,164
New +$2.16M 0.04% 158

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

TIAA CREF Trust's NVO Position: Q1 2017 in Review

TIAA CREF Trust reduced its Novo Nordisk (NVO) stake by 12% in Q1 2017, selling an estimated $63.8K and leaving 27,906 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #335.

TIAA CREF Trust first reported a position in NVO in Q1 2014 and has held it in 13 quarters since. The position peaked at $2.64M in Q1 2015. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • TIAA CREF Trust held 27,906 shares of Novo Nordisk worth $478K as of Q1 2017.
  • TIAA CREF Trust sold 3,666 Novo Nordisk shares in Q1 2017, an estimated $63.8K.
  • Novo Nordisk made up ﹤0.01% of TIAA CREF Trust's portfolio in Q1 2017, its #335 holding.
  • TIAA CREF Trust first reported a position in Novo Nordisk in Q1 2014 and has held it in 13 quarters since.
  • TIAA CREF Trust's Novo Nordisk position peaked at $2.64M in Q1 2015.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.